The role of liver NK cells in virus-induced severe viral hepatitis and, subsequently, hepatic failure is not well defined. In this study, we investigated the role of liver NK cells in the development of hepatocyte necrosis in fulminant hepatic failure (FHF)and acute-onchronic liver failure (ACLF) because of viral infection. A mouse model of FHF induced by murine hepatitis virus strain 3 (MHV-3) was used to study the role of liver NK cells. Samples from patients with hepatitis B virus-related ACLF (HBV-ACLF) were examined. After MHV-3 infection, the number of NK cells in livers of BALB/cJ mice increased markedly, peaked at 48 h postinfection, and remained at a high level until sacrifice. In peripheral blood, spleen, and bone marrow, this number decreased significantly. Expression of CD69, cytotoxic activity, and intracellular IFN-g and TNF-a production by liver NK cells at 48 h postinfection were all significantly upregulated. Depletion of NK cells 24 h post-MHV-3 infection increased the mice survival from 0 of 18 (0%) to 4 of 18 (22.2%). Highly activated liver NK cells were cytotoxic to MHV-3-infected hepatocytes and this effect was markedly inhibited by anti-Fas ligand (FasL) plus anti-NKG2D mAbs. Furthermore, the accumulation of hepatic NK cells and increased expression of FasL and natural cytotoxicity receptors (NKp30 and NKp46) on the peripheral NK cells from patients with HBV-ACLF were correlated with disease progression. These results indicate NK cells play a pivotal role in the pathogenesis of FHF and HBV-ACLF, in which process Fas/FasL and NKG2D/NKG2D ligand pathway contribute to the liver NK cell-mediated hepatocyte injury.
I
t is a challenge to treat patients with severe chronic hepatitis B (CHB) who undergo acute deterioration during the chronic phase and subsequently die of acute-on-chronic liver failure (ACLF). Fulminant hepatic failure (FHF) and ACLF because of hepatitis B virus (HBV) infection are the most common severe diseases requiring immediate hospitalization in China and many other Asian countries (1-5). The immunological mechanisms of virus-induced hepatic failure are still not fully defined. The role of immune cells, especially HBV-Ag-specific CTL, is crucial in understanding HBV-related ACLF (HBV-ACLF) (2, 6, 7), whereas the roles of innate immune cells, especially NK cells, remain obscure. NK cells are the first cellular responders after viral infection and they provide a first line of defense against viral infection (8). NK cells not only kill virus-infected cells directly but also produce a large amount of cytokines with direct antiviral activity such as IFN-g, TNF-a, and immunoregulating cytokines (such as IL-3, GM-CSF, and M-CSF) (9). Recently, NK cells were identified as adaptive immune response regulators by cross-talking with dendritic cells and T cells (10, 11). In addition, compared with the peripheral lymphatic system, NK cells are abundant in the liver and account for around one-third of intrahepatic lymphocytes (12, 13), implying a special role of this cell type in liver biology.
There is increasing evidence implicating liver NK cells in liver damage. Liver NK cells kill freshly isolated hepatocytes by a TRAIL/TRAIL receptor pathway in polyinosinic-polycytidylic acid-induced mouse liver injury (14) and induce severe liver injury through NKG2D/NKG2D ligand (NKG2DL) recognition after low-dose ConA stimulation in HBV transgenic mice (15). These findings can help to understand the role of liver NK cells in the pathogenesis of FHF, but the liver injuries in these models are all induced by chemical agents, and viral replication is absent. To explore the role of liver NK cells in the mechanism of virusinduced liver failure, a mouse model of FHF induced by murine hepatitis virus strain 3 (MHV-3) was established and patients with HBV-ACLF were also investigated. In the current study, MHV-3 induced activation and accumulation of liver NK cells with increased effector activity (i.e., enhanced release of IFN-g and TNFa and killing of MHV-3-infected hepatocytes through the Fas/Fas ligand [FasL] and NKG2D/NKG2DL pathways). Furthermore, the accumulation of hepatic NK cells and the upregulation of natural cytotoxicity receptors (NCRs) (NKp30 and NKp46) on peripheral NK cells in patients with HBV-ACLF were correlated with disease progression (as evaluated by total bilirubin level, prothrombinase time [PT] , and prothrombinase activity [PTA] ).
